General Cannabis showed solid gains across the board in its Q3 earnings report, with revenue and profits sharply up while expenses as a percentage of profit decreased.
Exceptional growth from companies like General Cannabis supports the theory that the medical marijuana industry is here to stay, and is only going to continue to grow.